Shenzhen Lifotronic Technology Co., Ltd. (SHA: 688389)

China flag China · Delayed Price · Currency is CNY
17.18
+0.95 (5.85%)
Oct 30, 2024, 3:00 PM CST
-20.02%
Market Cap 7.02B
Revenue (ttm) 1.19B
Net Income (ttm) 381.08M
Shares Out 428.44M
EPS (ttm) 0.89
PE Ratio 18.41
Forward PE 17.02
Dividend 0.28 (1.67%)
Ex-Dividend Date May 6, 2024
Volume 11,532,374
Open 16.17
Previous Close 16.23
Day's Range 15.92 - 17.35
52-Week Range 12.27 - 25.00
Beta 0.44
Analysts n/a
Price Target n/a
Earnings Date Oct 23, 2024

About Shenzhen Lifotronic Technology

Shenzhen Lifotronic Technology Co., Ltd. research, develops, manufactures, and markets medical devices for diagnostics, clinical medicine, skin, and human health related purposes in China. The company offers IVD products, such as HPLC, ECLIA, and hematology system; rapid test, molecular and POCT diagnostics. It also offers therapeutic products comprising respiratory and ICU, and wound care; electromagnetic and pneumatic shockwave products. In addition, the company provides medical and aesthetic, and laser hair removal products, as well as offer... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2008
Employees 1,481
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688389
Full Company Profile

Financial Performance

In 2023, Shenzhen Lifotronic Technology's revenue was 1.15 billion, an increase of 16.55% compared to the previous year's 983.04 million. Earnings were 328.58 million, an increase of 30.66%.

Financial Statements

News

There is no news available yet.